![Adjunct Professor Andreas Fouras](https://thelimbic.com/wordpress/wp-content/uploads/2018/05/Associate-Professor-Andreas-Fouras-300x169.jpeg)
4Dx president and CEO Adjunct Professor Andreas Fouras
Australian technology – a 4D, X-ray fluoroscopy-based take on lung function testing – can help pinpoint regional deficits in lung function that global measures such as spirometry cannot.
Presented at the ATS 2018 International Conference and with FDA approval pending, 4Dx will have application in both early detection of disease and management of disease progression.
4Dx chairman and CEO Andreas Fouras, an Adjunct Professor at Monash University and former research director of its Laboratory for Dynamic Imaging, told the limbic the technology provides much richer information than is currently available.
“I get little to no argument from respiratory physicians that the current measurements that they have don’t really inform them. They feel like the lung is hidden behind a wall inside a black box and they don’t really get good access to knowing what is happening inside a patient’s lungs.”
“We really provide very rich information. We can show exactly where the air is going and where the air is not going with a level of clarity and detail that nothing else can provide. And we can do that very safely and very inexpensively.”
Images are taken during a few breaths utilising existing X-ray fluoroscopes and are processed through 4Dx software to create airflow and ventilation reports.
Professor Fouras presented to the meeting a pre-clinical model of diaphragmatic hernia demonstrating that healthy regions of the lungs could compensate for diseased regions to hide functional deficits.